[HTML][HTML] Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - …, 2023 - thelancet.com
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - 2023 - cabidigitallibrary.org
Background: Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - …, 2023 - hal.univ-lorraine.fr
Background: Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - …, 2023 - hal.science
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation
with low-molecular-weight heparin on venous thromboembolism among noncritically and …
with low-molecular-weight heparin on venous thromboembolism among noncritically and …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez, O Empis de Vendin… - 2023 - lilloa.univ-lille.fr
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation
with low-molecular-weight heparin on venous thromboembolism among noncritically and …
with low-molecular-weight heparin on venous thromboembolism among noncritically and …
[HTML][HTML] Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - eClinicalMedicine, 2023 - Elsevier
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
[HTML][HTML] Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - …, 2023 - ncbi.nlm.nih.gov
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez… - …, 2023 - europepmc.org
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - …, 2023 - hal.science
Background: Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …